Open menu

Nanotechnology General News

The latest news from academia, regulators
research labs and other things of interest

Posted: February 12, 2008

Intertek Acquires BioClin Laboratory in Ireland

(Nanowerk News) Intertek Group plc (Intertek), the leading international provider of quality and safety services to a wide range of industries, has acquired BioClin Research Laboratories Ltd (BioClin).
BioClin is one of Ireland’s leading suppliers of contract bio-analysis and analytical research and development, with advanced analytical services including liquid chromatography-tandem mass spectrometry (LC/MS/MS). BioClin has been serving the local and international pharmaceutical, medical device and drug delivery industry for more than five years. Located in Athlone and with 20 staff, BioClin is highly regarded for its technical expertise, rigorous compliance programs, and outstanding customer service. The laboratory is Good Laboratory Practice (GLP) certified and is a current Good Manufacturing Practice (cGMP) facility that has been inspected by the IMB.
The acquisition advances Intertek’s strategic growth in expert support services to the global pharmaceutical, medical device and drug delivery industry. BioClin will operate in Intertek’s Pharmaceutical Services group within its Analytical Services division.
Dr. Andrew Swift, Executive Vice President of Intertek’s Analytical Services Division, comments: “BioClin has a strong reputation in the industry. Acquiring BioClin, further expands Intertek’s support globally to the pharmaceutical and related sectors for outsourced R&D and analytical services.”
Dr. John Conti-Ramsden, Global Director of Intertek’s Pharmaceutical Services, said: “BioClin further extends our offering in Europe as well as our global platform supporting pharmaceutical R&D and manufacturing in key locations. Intertek already provides a wide range of testing services to pharmaceutical clients from its laboratories in the United Kingdom, USA, India and Australia.”
Mary Burke, Managing Director and Brian McKenna Ph.D., Scientific Director of BioClin commented jointly: “Joining Intertek will allow BioClin’s local and international clients to gain from Intertek’s global network and surrounding experts and facilities give. It also gives BioClin an exciting opportunity to provide our expert services to a wider network of new international clients and markets.”
About Intertek:
Intertek Group plc (LSE:ITRK) is a leading international provider of quality and safety services to a wide range of global and local industries. Partnership with Intertek brings increased value to customers’ products and processes, supporting their success in the global market place. Intertek experience, expertise, resources and global reach support customers through a network of 21,000 people in more than 100 countries around the world. www.intertek.com
About Intertek’s Pharmaceutical services:
Intertek’s pharmaceutical and speciality chemical laboratories provide high-end routine and non-routine laboratory testing services to support pharmaceutical, biotechnology and nanotechnology clients. An international network of Intertek laboratories and offices serve clients from a wide range of industries on a global basis. Services include laboratory testing, outsourcing, inspection, R&D and process services. Intertek laboratories support a diverse range of fine chemical, pharmaceutical and biotech activities. www.intertek-pharma.com
About BioClin:
BioClin a leading GLP certified, FDA and cGMP compliant contract research laboratory, located in Ireland. BioClin integrates exceptional technical expertise and quality management with a range of related services, enabling BioClin to offer a complete range of development services to its clients. The BioClin team's many years experience in the drug delivery and biopharmaceutical industry gives them a unique understanding of clients’ development needs. www.bioclinlabs.com
Source: Intertek